In 2022, multiple sclerosis (MS) treatments performed in Australia and New Zealand had a market share of about 19.6 percent in the Asia Pacific region. The market share was forecast to gradually decline to around 16.9 percent by 2028.
Market share in the Asia Pacific (APAC) region of multiple sclerosis (MS) treatments performed in Australia and New Zealand from 2017 to 2022 with a forecast until 2028
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic U.S. number of venture capital deals for neurology companies 2006-2023
- Premium Statistic U.S. number of IPOs for neurology companies 2006-2023
- Basic Statistic U.S. venture investments in oncology companies 2006-2023
- Basic Statistic U.S. venture funding of therapeutic companies by disease type 2023
- Basic Statistic Total neurodegenerative funding by the National Institutes for Health 2013-2025
- Premium Statistic Eli Lilly's total revenue by segment 2022-2023
- Premium Statistic Eli Lilly's total revenue 2007-2023
- Premium Statistic Eli Lilly's net income 2007-2023
- Premium Statistic Sales of Johnson & Johnson's pharmaceutical products 2021-2023
- Premium Statistic Pharma market value in Chile 2008-2021
About the region
8
- Premium Statistic Number of people in a Home Care Package in Australia FY 2017-2021
- Premium Statistic Distribution of aged care consumers in Australia FY 2021, by service type
- Premium Statistic Distribution of HCPs in Australia FY 2021, by provider type
- Premium Statistic Distribution of HCPs in Australia FY 2021, by package level
- Premium Statistic Number of residential respite providers in Australia FY 2021, by state
- Premium Statistic Days of high and low care residential respite provided in Australia FY 2021, by state
- Premium Statistic Distribution of residential care places in Australia FY 2021, by provider type
- Premium Statistic Attitude towards using telemedicine in Australia 2018
Other regions
10
- Premium Statistic Average cost of nervous system treatments on the NHS in the United Kingdom 2016
- Basic Statistic Physiotherapists: number of employees in Slovenia 2002-2021
- Premium Statistic Number of Canadians leaving the country for plastic surgery in 2016, by province
- Basic Statistic Volume of medical cannabis sales in Denmark Q1 2018 to Q1 2023, by sector
- Premium Statistic Impact on working life for arthritis sufferers in Great Britain in 2018
- Premium Statistic Price variance of common medical procedures in Charlotte NC 2018
- Premium Statistic China's total investment in the treatment of environmental pollution 2007-2017
- Premium Statistic Hospitals with psychology department in Colombia 2015-2020
- Basic Statistic Physiotherapists: number of employees in Lithuania 2002-2021
- Basic Statistic Physiotherapists: number of employees in Italy 2012-2021
Further related statistics
1
Further Content: You might find this interesting as well
Reports and Insights. (April 6, 2023). Market share in the Asia Pacific (APAC) region of multiple sclerosis (MS) treatments performed in Australia and New Zealand from 2017 to 2022 with a forecast until 2028 [Graph]. In Statista. Retrieved May 27, 2024, from https://www.statista.com/statistics/1382090/anz-market-share-apac-ms-treatment/
Reports and Insights. "Market share in the Asia Pacific (APAC) region of multiple sclerosis (MS) treatments performed in Australia and New Zealand from 2017 to 2022 with a forecast until 2028." Chart. April 6, 2023. Statista. Accessed May 27, 2024. https://www.statista.com/statistics/1382090/anz-market-share-apac-ms-treatment/
Reports and Insights. (2023). Market share in the Asia Pacific (APAC) region of multiple sclerosis (MS) treatments performed in Australia and New Zealand from 2017 to 2022 with a forecast until 2028. Statista. Statista Inc.. Accessed: May 27, 2024. https://www.statista.com/statistics/1382090/anz-market-share-apac-ms-treatment/
Reports and Insights. "Market Share in The Asia Pacific (Apac) Region of Multiple Sclerosis (Ms) Treatments Performed in Australia and New Zealand from 2017 to 2022 with a Forecast until 2028." Statista, Statista Inc., 6 Apr 2023, https://www.statista.com/statistics/1382090/anz-market-share-apac-ms-treatment/
Reports and Insights, Market share in the Asia Pacific (APAC) region of multiple sclerosis (MS) treatments performed in Australia and New Zealand from 2017 to 2022 with a forecast until 2028 Statista, https://www.statista.com/statistics/1382090/anz-market-share-apac-ms-treatment/ (last visited May 27, 2024)
Market share in the Asia Pacific (APAC) region of multiple sclerosis (MS) treatments performed in Australia and New Zealand from 2017 to 2022 with a forecast until 2028 [Graph], Reports and Insights, April 6, 2023. [Online]. Available: https://www.statista.com/statistics/1382090/anz-market-share-apac-ms-treatment/